Boric acid + Procaine (Drops) Instructions for Use
ATC Code
S02AA30 (Combination of antimicrobial drugs)
Active Substances
Procaine (Rec.INN registered by WHO)
Boric acid (Ph.Eur. European Pharmacopoeia)
Clinical-Pharmacological Group
Drug with antimicrobial and local anesthetic action for topical use in ENT practice
Pharmacotherapeutic Groups
- Antimicrobial drugs in combination
- Means for the treatment of ear diseases; other means for the treatment of ear diseases; analgesics and anesthetics
Pharmacological Action
A combined drug for topical use, has antiseptic, disinfectant and local anesthetic action.
Boric acid has antiseptic, fungistatic action. It has a weak irritating effect on granulation tissues.
Procaine is a local anesthetic agent with moderate anesthetic activity and a wide therapeutic range. Being a weak base, it blocks sodium channels, prevents the generation of impulses in the endings of sensory nerves and the conduction of impulses along nerve fibers. It alters the action potential in the membranes of nerve cells without a pronounced effect on the resting potential. It suppresses the conduction of not only pain but also impulses of other modalities.
Pharmacokinetics
Boric acid is absorbed through damaged skin, wound surfaces, mucous membranes. In young children, it penetrates especially well through the skin and mucous membranes (fatal outcomes have been described with accidental ingestion or application to damaged skin). It is excreted slowly (accumulates with repeated administration). About 50% is excreted in the urine within 12 hours, the remainder within 5-7 days.
Procaine undergoes complete systemic absorption. The degree of absorption depends on the site and route of administration (especially on the vascularization and blood flow rate in the area of administration) and the final dose (amount and concentration). It is rapidly hydrolyzed by plasma and liver esterases to form two main pharmacologically active metabolites: diethylaminoethanol (has a moderate vasodilating effect) and para-aminobenzoic acid (PABA) (is a competitive antagonist of sulfonamide chemotherapeutic drugs and may weaken their antimicrobial effect). T1/2 is 30-50 s, in the neonatal period – 54-114 s. It is excreted mainly by the kidneys in the form of metabolites, no more than 2% is excreted unchanged.
Indications
External acute and chronic otitis without damage to the tympanic membrane.
ICD codes
| ICD-10 code | Indication |
| H60 | Otitis externa |
| ICD-11 code | Indication |
| AA3Z | Otitis externa, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Drops
The drug is used topically, by instillation into the external auditory canal.
To avoid unpleasant sensations associated with cold liquid entering the ear canal, it is recommended to warm the bottle by holding it in your hand before using the ear drops.
Adults are prescribed 2-3 drops 2-3 times/day; children – 1-2 drops 2-3 times/day. A tampon soaked in the solution can be placed in the external auditory canal.
The duration of the course of therapy is no more than 7 days.
The drops should be instilled to the patient lying on their side so that the affected ear is on top. After the procedure, the patient should remain in this position for several minutes.
Adverse Reactions
Systemic reactions possibly – allergic reactions (skin rash, epithelial desquamation, confusion, convulsions, oliguria, rarely – anaphylactic shock); with prolonged use, headache, nausea, vomiting, diarrhea may be observed.
Local reactions itching, burning, which disappear on their own after 1-2 minutes and do not require discontinuation of the drug.
Toxic reactions in case of use with a perforated tympanic membrane nausea, vomiting, skin redness, itching, urticaria, swelling, deafness, balance disorder, confusion.
Contraindications
Violation of the integrity of the tympanic membrane, chronic renal failure, pregnancy, lactation period, children under 1 year of age, hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
The use of the drug during pregnancy and breastfeeding is contraindicated.
Use in Renal Impairment
The use of the drug is contraindicated in chronic renal failure.
Pediatric Use
The use of the drug is contraindicated in children under 1 year of age.
Special Precautions
Avoid contact with mucous membranes.
Before starting to use the drug, it is necessary to ensure the integrity of the tympanic membrane. In case of use with a perforated tympanic membrane, the drug may lead to toxic reactions.
Effect on the ability to drive vehicles and mechanisms
During treatment with the drug, caution should be exercised when engaging in potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Drug Interactions
The metabolite of procaine (para-aminobenzoic acid) is an antagonist of sulfonamides, so a decrease in the antimicrobial effect of sulfonamide drugs is possible in case of simultaneous use with the drug.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Ear drops 30 mg/ml+20 mg/ml
Marketing Authorization Holder
West, LLC (Russia)
Manufactured By
Samaramedprom, OJSC (Russia)
Dosage Form
| Boric acid + Procaine | Ear drops 30 mg/ml+20 mg/ml |
Dosage Form, Packaging, and Composition
Ear drops
| 1 ml | |
| Boric acid | 30 mg |
| Procaine | 20 mg |
10 ml – dropper bottle – cardboard packs – Over-the-Counter
10 ml – bottles – cardboard packs – Over-the-Counter
15 ml – dropper bottle – cardboard packs – Over-the-Counter
15 ml – bottles – cardboard packs – Over-the-Counter
20 ml – dropper bottle – cardboard packs – Over-the-Counter
20 ml – bottles – cardboard packs – Over-the-Counter
25 ml – dropper bottle – cardboard packs – Over-the-Counter
25 ml – bottles – cardboard packs – Over-the-Counter
Ear drops 20 mg+30 mg/1 ml: 10 ml, 15 ml, 20 ml or 25 ml bottle
Marketing Authorization Holder
West, LLC (Russia)
Manufactured By
Samaramedprom, OJSC (Russia)
Dosage Form
| Boric acid + Procaine | Ear drops 20 mg+30 mg/1 ml: 10 ml, 15 ml, 20 ml or 25 ml bottle |
Dosage Form, Packaging, and Composition
Ear drops in the form of a transparent, colorless or slightly yellowish or yellowish-brown liquid with a characteristic odor.
| 1 ml | |
| Procaine hydrochloride | 20 mg |
| Boric acid | 30 mg |
Excipients : ethanol 70% – up to 1 ml.
10 ml – orange glass dropper bottles (1) – cardboard packs.
15 ml – orange glass dropper bottles (1) – cardboard packs.
20 ml – orange glass dropper bottles (1) – cardboard packs.
25 ml – orange glass dropper bottles (1) – cardboard packs.
10 ml – polymer bottles (1) – cardboard packs.
15 ml – polymer bottles (1) – cardboard packs.
20 ml – polymer bottles (1) – cardboard packs.
25 ml – polymer bottles (1) – cardboard packs.
Ear drops 3%+2%: 10 ml or 25 ml bottle or dropper bottle
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
| Boric acid + Procaine | Ear drops 3%+2%: 10 ml or 25 ml bottle or dropper bottle |
Dosage Form, Packaging, and Composition
Ear drops transparent colorless or slightly colored solution with a characteristic odor.
| 1 ml | |
| Boric acid | 30 mg |
| Procaine hydrochloride | 20 mg |
Excipients : ethanol (ethyl alcohol) 70% – up to 1 ml.
10 ml – dropper bottle (1) – cardboard packs.
10 ml – bottles (1) – cardboard packs.
25 ml – dropper bottle (1) – cardboard packs.
25 ml – bottles (1) – cardboard packs.
Ear drops 20 mg/1 ml+30 mg/1 ml: 10 ml bottle
Marketing Authorization Holder
Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
| Boric acid + Procaine | Ear drops 20 mg/1 ml+30 mg/1 ml: 10 ml bottle |
Dosage Form, Packaging, and Composition
Ear drops in the form of a transparent, colorless or slightly yellowish liquid with a characteristic odor.
| 1 ml | |
| Procaine hydrochloride | 20 mg |
| Boric acid | 30 mg |
Excipients : sodium hydroxide solution 0.1M – to pH 4.5-6.0, ethanol (ethyl alcohol) 70% – up to 1 ml.
10 ml – orange glass dropper bottles (1) with a pipette (dropper) – cardboard packs.
